PD
Point72 (DIFC) Portfolio holdings
AUM
$1.25B
1-Year Return
9.31%
This Quarter Return
+3.57%
1 Year Return
+9.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.29B
AUM Growth
+$163M
(+14%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
9.85%
Top 10 Holdings %
Top 10 Hldgs %
21.22%
Holding
1,544
New
511
Increased
141
Reduced
207
Closed
507
Top Buys
| 1 |
Bruker
BRKR
|
+$31.8M |
| 2 |
Adobe
ADBE
|
+$30.2M |
| 3 |
Qiagen
QGEN
|
+$29.3M |
| 4 |
McKesson
MCK
|
+$27.3M |
| 5 |
Alibaba
BABA
|
+$24.2M |
Top Sells
| 1 |
Apple
AAPL
|
+$33.9M |
| 2 |
Amazon
AMZN
|
+$28.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$26.6M |
| 4 |
Pfizer
PFE
|
+$24.9M |
| 5 |
RTX Corp
RTX
|
+$24.8M |
Sector Composition
| 1 | Healthcare | 30.64% |
| 2 | Technology | 15.16% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Industrials | 11.38% |
| 5 | Financials | 11.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Ginkgo Bioworks
DNA
$609M
| $493 | ﹤0.01% |
60
-1,834
| -97% | -$15.1K |
|
|
TRTX
827
TPG RE Finance Trust
TRTX
$744M
| $402 | ﹤0.01% |
47
-1,792
| -97% | -$15.3K |
|
828
Energy Vault
NRGV
$309M
| $385 | ﹤0.01% |
401
-7,199
| -95% | -$6.91K |
|
829
Design Therapeutics
DSGN
$349M
| $362 | ﹤0.01% |
+67
| New | +$362 |
|
830
Solarmax Technology
SMXT
$59.2M
| $354 | ﹤0.01% |
+561
| New | +$354 |
|
|
ONL
831
Orion Office REIT
ONL
$165M
| $300 | ﹤0.01% |
+75
| New | +$300 |
|
832
Sandstorm Gold
SAND
$3.4B
| $294 | ﹤0.01% |
49
-3,994
| -99% | -$24K |
|
833
uniQure
QURE
$959M
| $261 | ﹤0.01% |
53
| – | – |
|
834
Blue Owl Capital
OBDC
$7.23B
| $242 | ﹤0.01% |
17
| – | – |
|
835
ClearPoint Neuro
CLPT
$299M
| $224 | ﹤0.01% |
20
-5,990
| -100% | -$67.1K |
|
836
Metagenomi
MGX
$69.1M
| $210 | ﹤0.01% |
97
-2,198
| -96% | -$4.76K |
|
837
Sigma Lithium
SGML
$610M
| $200 | ﹤0.01% |
16
-3,987
| -100% | -$49.8K |
|
838
PDS Biotechnology
PDSB
$57.8M
| $191 | ﹤0.01% |
50
-5,030
| -99% | -$19.2K |
|
839
Hudson Technologies
HDSN
$441M
| $176 | ﹤0.01% |
21
-6,181
| -100% | -$51.8K |
|
840
Origin Bancorp
OBK
$1.18B
| $161 | ﹤0.01% |
+5
| New | +$161 |
|
841
Camtek
CAMT
$3.71B
| $160 | ﹤0.01% |
+2
| New | +$160 |
|
|
WHWK
842
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.4M
| $159 | ﹤0.01% |
77
-4,811
| -98% | -$9.93K |
|
843
Anika Therapeutics
ANIK
$121M
| $148 | ﹤0.01% |
6
-389
| -98% | -$9.6K |
|
844
Adicet Bio
ACET
$66.9M
| $137 | ﹤0.01% |
95
-33,346
| -100% | -$48.1K |
|
845
Aclaris Therapeutics
ACRS
$221M
| $106 | ﹤0.01% |
92
-18,227
| -99% | -$21K |
|
846
BioAtla
BCAB
$39.2M
| $84 | ﹤0.01% |
48
-17,213
| -100% | -$30.1K |
|
847
FTC Solar
FTCI
$94.3M
| $61 | ﹤0.01% |
9
-964
| -99% | -$6.53K |
|
848
HealthStream
HSTM
$839M
| $57 | ﹤0.01% |
2
-1,371
| -100% | -$39.1K |
|
|
MRNS
849
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $49 | ﹤0.01% |
28
-23,670
| -100% | -$41.4K |
|
850
Origin Materials
ORGN
$80.2M
| $48 | ﹤0.01% |
31
-55,890
| -100% | -$86.5K |
|